Quantcast

Posts related to ‘PCOP’

Biotech Bonanza: Ligand Takes out Pharmacopeia (LGND, PCOP)

This might not be the biggest of biotech mergers out there, but deals are continuing in the bio-space.  Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) has entered into a definitive merger agreement ...
Read Full Story »

Hypertension Results Drive Pharmacopeia (PCOP)

Pharmacopeia, Inc. (NASDAQ: PCOP) is seeing shares surge in pre-market and at the open of trading today.The company said that PS433540, its first-in-class Dual Acting Receptor Antagonist, showed statistically significant ...
Read Full Story »

Pharmacopeia Scores Another Milestone (PCOP, GSK)

Pharmacopeia (Nasdaq: PCOP) has announced that it will receive a milestone payment of $5 million from GlaxoSmithKline (NYSE: GSK), bringing the total received to over $16 million in connection with ...
Read Full Story »

The Day In Biotech Stocks (January 28, 2008) (ACOR, BIIB, CELG, PHRM, CRXX, LIPD, MDVN, PCOP)

Acorda Therapeutics inc. (NASDAQ: ACOR) showed late stage trial results on its drug candidate Fampridine-SR for treating multiple sclerosis.  This data showed that Fampridine, which is designed to treat multiple ...
Read Full Story »

Pre-Market Stock News (November 27, 2007)

Below is a snapshot of much of the pre-market news moving individual stocks this morning:Activision (ATVI) raised guidance on Guitar Hero III sales; stock up 8% pre-market.Barrier Therapeutics (BTRX) announced ...
Read Full Story »